Laboratory Medicine ›› 2024, Vol. 39 ›› Issue (3): 265-271.DOI: 10.3969/j.issn.1673-8640.2024.03.010
Previous Articles Next Articles
MA Chen, ZHANG Yi, LI Fang, WANG Jing, CHEN Wei()
Received:
2022-12-06
Revised:
2024-01-24
Online:
2024-03-30
Published:
2024-04-24
CLC Number:
MA Chen, ZHANG Yi, LI Fang, WANG Jing, CHEN Wei. Clinical characteristics,drug resistance and poor prognosis factors in children with invasive pneumococcal disease with necrotizing pneumonia[J]. Laboratory Medicine, 2024, 39(3): 265-271.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2024.03.010
组别 | 例数 | 性别 | 年龄/岁 | CRP/(mg·L-1) | WBC计数/ (×109/L) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
男/[例(%)] | 女/[例(%)] | |||||||||||||||
观察组 | 158 | 85(53.80) | 73(46.20) | 5.39±1.74 | 162.78±28.24 | 21.65±6.34 | ||||||||||
对照组 | 92 | 54(58.70) | 38(41.30) | 5.01±1.42 | 95.82±24.31 | 9.72±2.26 | ||||||||||
统计值 | 0.565 | 1.778 | 19.006 | 17.404 | ||||||||||||
P值 | 0.452 | 0.077 | <0.001 | <0.001 | ||||||||||||
组别 | NEUT#/(×109/L) | LDH/(U·L-1) | IL-4/(pg·mL-1) | IL-6/(pg·mL-1) | TNF-α/(pg·mL-1) | PCT/(μg·L-1) | ||||||||||
观察组 | 0.88±0.21 | 598.67±195.48 | 3.72±1.16 | 65.92±15.14 | 2.69±0.86 | 2.86±0.94 | ||||||||||
对照组 | 0.76±0.25 | 556.75±128.93 | 3.45±1.04 | 62.75±13.96 | 2.34±0.67 | 1.39±0.41 | ||||||||||
统计值 | 4.058 | 1.837 | 1.842 | 1.642 | 3.355 | 14.223 | ||||||||||
P值 | <0.001 | 0.067 | 0.067 | 0.102 | 0.001 | <0.001 | ||||||||||
组别 | 临床表现 | |||||||||||||||
发热时间/d | 气促/[例(%)] | 呼吸音减弱/[例(%)] | 肺部湿啰音/[例(%)] | 咳嗽咳痰/[例(%)] | ||||||||||||
观察组 | 16.78±4.35 | 64(40.51) | 112(70.89) | 86(54.43) | 131(82.91) | |||||||||||
对照组 | 14.02±4.17 | 21(22.83) | 56(60.87) | 43(46.74) | 78(84.78) | |||||||||||
统计值 | 4.912 | 8.100 | 2.647 | 1.377 | 0.148 | |||||||||||
P值 | <0.001 | 0.004 | 0.104 | 0.241 | 0.700 |
组别 | 例数 | 性别 | 年龄/岁 | CRP/(mg·L-1) | WBC计数/ (×109/L) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
男/[例(%)] | 女/[例(%)] | |||||||||||||||
观察组 | 158 | 85(53.80) | 73(46.20) | 5.39±1.74 | 162.78±28.24 | 21.65±6.34 | ||||||||||
对照组 | 92 | 54(58.70) | 38(41.30) | 5.01±1.42 | 95.82±24.31 | 9.72±2.26 | ||||||||||
统计值 | 0.565 | 1.778 | 19.006 | 17.404 | ||||||||||||
P值 | 0.452 | 0.077 | <0.001 | <0.001 | ||||||||||||
组别 | NEUT#/(×109/L) | LDH/(U·L-1) | IL-4/(pg·mL-1) | IL-6/(pg·mL-1) | TNF-α/(pg·mL-1) | PCT/(μg·L-1) | ||||||||||
观察组 | 0.88±0.21 | 598.67±195.48 | 3.72±1.16 | 65.92±15.14 | 2.69±0.86 | 2.86±0.94 | ||||||||||
对照组 | 0.76±0.25 | 556.75±128.93 | 3.45±1.04 | 62.75±13.96 | 2.34±0.67 | 1.39±0.41 | ||||||||||
统计值 | 4.058 | 1.837 | 1.842 | 1.642 | 3.355 | 14.223 | ||||||||||
P值 | <0.001 | 0.067 | 0.067 | 0.102 | 0.001 | <0.001 | ||||||||||
组别 | 临床表现 | |||||||||||||||
发热时间/d | 气促/[例(%)] | 呼吸音减弱/[例(%)] | 肺部湿啰音/[例(%)] | 咳嗽咳痰/[例(%)] | ||||||||||||
观察组 | 16.78±4.35 | 64(40.51) | 112(70.89) | 86(54.43) | 131(82.91) | |||||||||||
对照组 | 14.02±4.17 | 21(22.83) | 56(60.87) | 43(46.74) | 78(84.78) | |||||||||||
统计值 | 4.912 | 8.100 | 2.647 | 1.377 | 0.148 | |||||||||||
P值 | <0.001 | 0.004 | 0.104 | 0.241 | 0.700 |
组别 | 例数 | LDH/(U·L-1) | WBC计数/(×109/L) | 葡萄糖/(mmol·L-1) |
---|---|---|---|---|
观察组 | 143 | 3 817.52±846.39 | 5.21±1.16 | 5.48±1.59 |
对照组 | 52 | 2 286.74±416.35 | 0.82±0.23 | 0.57±0.18 |
统计值 | 12.489 | 27.055 | 22.181 | |
P值 | <0.001 | <0.001 | <0.001 |
组别 | 例数 | LDH/(U·L-1) | WBC计数/(×109/L) | 葡萄糖/(mmol·L-1) |
---|---|---|---|---|
观察组 | 143 | 3 817.52±846.39 | 5.21±1.16 | 5.48±1.59 |
对照组 | 52 | 2 286.74±416.35 | 0.82±0.23 | 0.57±0.18 |
统计值 | 12.489 | 27.055 | 22.181 | |
P值 | <0.001 | <0.001 | <0.001 |
药物 | 敏感 | 中介 | 耐药 |
---|---|---|---|
青霉素 | 95(60.13) | 46(29.11) | 17(10.76) |
万古霉素 | 158(100.00) | 0(0.00) | 0(0.00) |
红霉素 | 0(0.00) | 0(0.00) | 158(100.00) |
头孢噻肟 | 118(74.68) | 28(17.72) | 12(7.59) |
头孢吡肟 | 63(39.88) | 73(46.20) | 22(13.92) |
克林霉素 | 5(3.16) | 0(0.00) | 153(96.84) |
四环素 | 71(44.94) | 0(0.00) | 87(55.06) |
复方磺胺甲噁唑 | 44(27.85) | 24(15.19) | 90(56.96) |
左氧氟沙星 | 158(100.00) | 0(0.00) | 0(0.00) |
利奈唑胺 | 158(100.00) | 0(0.00) | 0(0.00) |
药物 | 敏感 | 中介 | 耐药 |
---|---|---|---|
青霉素 | 95(60.13) | 46(29.11) | 17(10.76) |
万古霉素 | 158(100.00) | 0(0.00) | 0(0.00) |
红霉素 | 0(0.00) | 0(0.00) | 158(100.00) |
头孢噻肟 | 118(74.68) | 28(17.72) | 12(7.59) |
头孢吡肟 | 63(39.88) | 73(46.20) | 22(13.92) |
克林霉素 | 5(3.16) | 0(0.00) | 153(96.84) |
四环素 | 71(44.94) | 0(0.00) | 87(55.06) |
复方磺胺甲噁唑 | 44(27.85) | 24(15.19) | 90(56.96) |
左氧氟沙星 | 158(100.00) | 0(0.00) | 0(0.00) |
利奈唑胺 | 158(100.00) | 0(0.00) | 0(0.00) |
组别 | 例数 | 性别/[例(%)] | 年龄/岁 | 呼吸音减弱/ [例(%)] | CRP/ (mg·L-1) | WBC/ (×109/L) | |
---|---|---|---|---|---|---|---|
男 | 女 | ||||||
预后不良组 | 26 | 14(53.85) | 12(46.15) | 5.15±1.52 | 21(80.77) | 172.39±29.82 | 24.82±6.63 |
预后良好组 | 132 | 73(55.30) | 59(44.70) | 5.44±1.78 | 91(68.94) | 160.89±24.51 | 21.03±5.01 |
统计值 | 0.019 | 0.776 | 1.473 | 2.107 | 3.331 | ||
P值 | 0.891 | 0.439 | 0.225 | 0.037 | 0.001 | ||
组别 | NEUT#/ (×109/L) | LDH/ (U·L-1) | IL-4/ (pg·mL-1) | IL-6/ (pg·mL-1) | TNF-α/ (pg·mL-1) | PCT/ (μg·L-1) | 血钠/(mmol·L-1) |
预后不良组 | 1.09±0.28 | 603.48±198.46 | 4.08±1.02 | 68.47±16.83 | 3.14±0.96 | 3.26±0.97 | 125.94±24.86 |
预后良好组 | 0.84±0.21 | 597.72±184.35 | 3.65±1.19 | 65.42±14.81 | 2.60±0.85 | 2.78±0.84 | 139.82±31.59 |
统计值 | 5.232 | 0.144 | 1.721 | 0.938 | 2.898 | 2.595 | 2.113 |
P值 | <0.001 | 0.886 | 0.087 | 0.350 | 0.004 | 0.010 | 0.036 |
组别 | 血钙/(mmol·L-1) | 临床表现 | |||||
发热时间/d | 气促/[例(%)] | 肺部湿啰音/ [例(%)] | 咳嗽咳痰/ [例(%)] | 胸腔积液/ [例(%)] | |||
预后不良组 | 1.86±0.52 | 17.42±4.46 | 14(53.85) | 18(69.23) | 24(92.31) | 26(100.00) | |
预后良好组 | 2.31±0.74 | 16.65±4.31 | 50(37.88) | 68(51.52) | 107(81.06) | 117(88.64) | |
统计值 | 2.957 | 0.828 | 2.298 | 2.748 | 1.939 | 3.264 | |
P值 | 0.004 | 0.409 | 0.130 | 0.097 | 0.164 | 0.071 |
组别 | 例数 | 性别/[例(%)] | 年龄/岁 | 呼吸音减弱/ [例(%)] | CRP/ (mg·L-1) | WBC/ (×109/L) | |
---|---|---|---|---|---|---|---|
男 | 女 | ||||||
预后不良组 | 26 | 14(53.85) | 12(46.15) | 5.15±1.52 | 21(80.77) | 172.39±29.82 | 24.82±6.63 |
预后良好组 | 132 | 73(55.30) | 59(44.70) | 5.44±1.78 | 91(68.94) | 160.89±24.51 | 21.03±5.01 |
统计值 | 0.019 | 0.776 | 1.473 | 2.107 | 3.331 | ||
P值 | 0.891 | 0.439 | 0.225 | 0.037 | 0.001 | ||
组别 | NEUT#/ (×109/L) | LDH/ (U·L-1) | IL-4/ (pg·mL-1) | IL-6/ (pg·mL-1) | TNF-α/ (pg·mL-1) | PCT/ (μg·L-1) | 血钠/(mmol·L-1) |
预后不良组 | 1.09±0.28 | 603.48±198.46 | 4.08±1.02 | 68.47±16.83 | 3.14±0.96 | 3.26±0.97 | 125.94±24.86 |
预后良好组 | 0.84±0.21 | 597.72±184.35 | 3.65±1.19 | 65.42±14.81 | 2.60±0.85 | 2.78±0.84 | 139.82±31.59 |
统计值 | 5.232 | 0.144 | 1.721 | 0.938 | 2.898 | 2.595 | 2.113 |
P值 | <0.001 | 0.886 | 0.087 | 0.350 | 0.004 | 0.010 | 0.036 |
组别 | 血钙/(mmol·L-1) | 临床表现 | |||||
发热时间/d | 气促/[例(%)] | 肺部湿啰音/ [例(%)] | 咳嗽咳痰/ [例(%)] | 胸腔积液/ [例(%)] | |||
预后不良组 | 1.86±0.52 | 17.42±4.46 | 14(53.85) | 18(69.23) | 24(92.31) | 26(100.00) | |
预后良好组 | 2.31±0.74 | 16.65±4.31 | 50(37.88) | 68(51.52) | 107(81.06) | 117(88.64) | |
统计值 | 2.957 | 0.828 | 2.298 | 2.748 | 1.939 | 3.264 | |
P值 | 0.004 | 0.409 | 0.130 | 0.097 | 0.164 | 0.071 |
[1] |
YANG B, ZHANG W, GU W, et al. Differences of clinical features and prognosis between Mycoplasma pneumoniae necrotizing pneumonia and non-Mycoplasma pneumoniae necrotizing pneumonia in children[J]. BMC Infect Dis, 2021, 21(1):797.
DOI |
[2] |
MAREK O, TMA J, PAPEŽ J, et al. Retrospective analysis of necrotizing pneumonia in children between 2015-2019[J]. Rozhl Chir, 2022, 101(2):72-78.
DOI PMID |
[3] |
HUANG J, ZHANG T, ZOU X, et al. Panton-valentine leucocidin carrying Staphylococcus aureus causing necrotizing pneumonia inactivates the JAK/STAT signaling pathway and increases the expression of inflammatory cytokines[J]. Infect Genet Evol, 2020, 86:104582.
DOI URL |
[4] |
FITZGERALD D, WATERER G W. Invasive pneumococcal and meningococcal disease[J]. Infect Dis Clin N Am, 2019, 33(4):1125-1141.
DOI PMID |
[5] |
BAJEMA K L, GIERKE R, FARLEY M M, et al. Impact of pneumococcal conjugate vaccines on antibiotic-nonsusceptible invasive pneumococcal disease in the United States[J]. J Infect Dis, 2022, 226(2):342-351.
DOI PMID |
[6] | 郭莹, 乔莉娜. 儿童侵袭性与非侵袭性肺炎链球菌病临床特征及耐药性分析[J]. 中国当代儿科杂志, 2021, 23(5):466-470. |
[7] | 叶应妩, 王毓三, 申子瑜. 全国临床检验操作规程[M]. 3版. 南京: 东南大学出版社, 2006. |
[8] | Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. M100-28,CLSI, 2018. |
[9] |
SHARMA P K, VINAYAK N, AGGARWAL G K, et al. Severe necrotizing pneumonia in children:a challenge to intensive care specialist[J]. J Trop Pediatrics, 2020, 66(6):637-644.
DOI URL |
[10] |
NESS-COCHINWALA M, KOBAITRI K, TOTAPALLY B R. Characteristics and outcomes of children with necrotizing pneumonia[J]. Pediatr Crit Care Med, 2021, 22(12):e640-e643.
DOI URL |
[11] | 李沁原, 李媛媛, 易茜, 等. 儿童侵袭性肺炎链球菌疾病临床特点及耐药性分析[J]. 中华实用儿科临床杂志, 2020, 35(8):586-589. |
[12] |
RYMAN J, WEAVER J, YEE K,L, et al. Predicting effectiveness of the V114 vaccine against invasive pneumococcal disease in children[J]. Expert Rev Vaccines, 2022, 21(10):1515-1521.
DOI URL |
[13] | 岳敬卫, 王立军, 苏宇飞, 等. 难治性肺炎支原体肺炎患儿维生素A、IL-6、IFN-γ、IL-10水平分析[J]. 检验医学与临床, 2020, 17(6):4. |
[14] | 杨男, 尚云晓. 儿童肺炎链球菌感染致坏死性肺炎的临床特点及预测指标研究[J]. 中华实用儿科临床杂志, 2020, 35(8):573-577. |
[15] | 桑希智, 盛华西. 儿童细菌性坏死性肺炎与肺炎支原体坏死性肺炎的临床特征与预后分析[J]. 国际免疫学杂志, 2021, 44(4):395-400. |
[16] | 费文祎, 罗健. 儿童坏死性肺炎诊治进展[J]. 临床儿科杂志, 2018, 36(4):306-310. |
[17] |
SHABESTARI A A, IMANPARAST F, MOHAGHEGH P, et al. The effects of asthma on the oxidative stress,inflammation,and endothelial dysfunction in children with pneumonia[J]. BMC Pediatr, 2022, 22(1):534.
DOI |
[18] |
ADIGUZEL A, ARSAVA E M, TOPCUOGLU M A. Temporal course of peripheral inflammation markers and indexes following acute ischemic stroke:prediction of mortality,functional outcome,and stroke-associated pneumonia[J]. Neurol Res, 2022, 44(3):224-231.
DOI URL |
[19] | 尹加林, 魏静, 徐坤, 等. 齐齐哈尔市156例小儿社区获得性肺炎的病原学特点及影响预后的相关因素分析[J]. 中国病原生物学杂志, 2021, 16(3):352-355. |
[20] | 李佳, 刘超, 胡姝雯, 等. 血清降钙素原、高迁移率族蛋白1及急性生理与慢性健康评分系统Ⅱ评分对重症肺炎患儿预后的评估[J]. 中国临床医生杂志, 2021, 49(12):1494-1497. |
[21] | 丁利, 宋伟, 朱雪萍. 新生儿呼吸机相关性肺炎病原学及不良预后高危因素分析[J]. 中国实用儿科杂志, 2020, 35(11):877-880. |
[1] | FANG Dandong, CHENG Gang, HUANG Wei, LIU Xiaonan, MAO Jian, HOU Baosen, LIU Shimin. Expression of lncRNA SOX21-AS1 and miR-875-5p in glioma tissues and relationship with prognosis of patients [J]. Laboratory Medicine, 2024, 39(3): 209-214. |
[2] | YU Feng, HU Longhua, XIAO Yanping, YANG Junping. Virulence genes and molecular characteristics of Klebsiella pneumoniae isolated from bloodstream infection patients [J]. Laboratory Medicine, 2024, 39(3): 249-255. |
[3] | CHEN Yu, ZHAO Ya, WANG Lin. Microbial distribution and drug resistance in chronic dacryocystitis [J]. Laboratory Medicine, 2024, 39(3): 256-259. |
[4] | CHEN Huan, DONG Fang, LÜ Zhiyong, ZHEN Jinghui, CHEN Mei, SU Jianrong. Serotypes and drug resistance of invasive Streptococcus agalactiae in children [J]. Laboratory Medicine, 2024, 39(3): 260-264. |
[5] | LU Chao, HAN Huijuan, DI Hua, MU Yanchao. Pedigree analysis of dilated cardiomyopathy type 1S caused by MYH7 c.1574AG variation [J]. Laboratory Medicine, 2024, 39(2): 138-142. |
[6] | SONG Xiaolong, QIN Jinlü, YANG Ru, WEI Long, ZHOU Jianping. Application of serum TK1 in postoperative monitoring of thyroid papillary carcinoma patients [J]. Laboratory Medicine, 2024, 39(2): 155-160. |
[7] | ZHANG Miaomiao, DUAN Dongkui, YU Chun, WANG Lina. Expression and prognostic assessment value of miR-924 and SLC1A5 in lung cancer tissues [J]. Laboratory Medicine, 2024, 39(1): 13-18. |
[8] | WANG Yanyan, WANG Junrui, ZHENG Wenqi, LAN Haixia, GUO Sufang. Drug resistance of Bacteroides isolated from clinic and characteristics of Bacteroides fragilis bft genotyping [J]. Laboratory Medicine, 2024, 39(1): 47-52. |
[9] | LAN Jun, LU Shuting, YANG Jianrui. Roles of serum IL-26 and IL-27 levels in patients with colorectal cancer [J]. Laboratory Medicine, 2024, 39(1): 7-12. |
[10] | WANG Yangshuyi, YE WEI, LIN Zhihao, HUANG Yuenuo, FANG Tao, DONG Xiaoting. Construction and validation of a model for pyroptosis-related features in lung adenocarcinoma [J]. Laboratory Medicine, 2023, 38(9): 833-841. |
[11] | ZHANG Han, LI Jun, LIU Xiaojiang, GUAN Yixiang. Role of serum albumin,interleukin-6 and ferritin combined determination in evaluating the functional prognosis of patients with spontaneous intracerebral hemorrhage [J]. Laboratory Medicine, 2023, 38(8): 713-718. |
[12] | ZHANG Na, NIU Weihua, SUN Yuanyuan, JIA Mei. CMV and EBV co-infection affecting patient prognosis after hematopoietic stem cell transplantation [J]. Laboratory Medicine, 2023, 38(8): 760-765. |
[13] | WANG Chao, ZHAO Yu. Research progress on formation mechanism and eradication strategy of bacterial persisters [J]. Laboratory Medicine, 2023, 38(8): 790-795. |
[14] | GUO Jie, LI Haixia, LI Xiaoyun. Correlation of preoperative RPR in peripheral blood with the prognosis of endometrial carcinoma patients [J]. Laboratory Medicine, 2023, 38(7): 675-679. |
[15] | WANG Tengfei, CHEN Shan, AN Hebing, ZHOU Lei. Expressions and roles of lncRNA CRNDE and miR-384 in peripheral blood of patients with acute leukemia [J]. Laboratory Medicine, 2023, 38(7): 686-691. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||